Drug Maker Rolls Out a Price Transparency Policy
By Max NisenOne challenge for J&J: Patients with high-deductible plans might pay something close to the full list price…
February 08, 2019
How Web Stink (and Desk Piles) Murder Your SalesWhen life and annuity prospects do notice you… is that a good thing?
February 06, 2019
Top Tech Rollouts, Trends From T3From new cloud-based ventures to the latest software for estate planning and retirement tools, the conference highlighted best-in-class digital strategies.
February 06, 2019
How to Hire Next-Gen AdvisorsYoung advisors can have a major impact on your advisory firm if you have a clear vision of what you want and bring them on board carefully.
February 05, 2019
401(k) Millionaires Club Got Smaller Last YearFor those who thought markets only go up, 2018 was an unwelcome surprise.
February 04, 2019
Beware Trump Drug Price Crackdowns That Make Pharma SmileDrug manufacturers could slink around a proposed rebate curb by increasing products' list prices.
February 04, 2019
ESG: A Trend That Pays Off in Performance?Here are some return and risk analytics to help financial advisors come to conclusions regarding ESG-style investing.
February 01, 2019
Good News for Indemnity Based LTC CoverageAn LTC policy veteran explains why a recent IRS revenue procedure could be good for your clients.
Commentary